Strumento inattivo

Pubblicazioni ufficiali NOVARTIS London S.E.

Azioni

Prezzo di chiusura London S.E. Altri mercati azionari
- ^GBX	-

10/05	Borsa svizzera: chiusura in rialzo, SMI +1,31%	AW
10/05	Scemblix di Novartis ottiene la terza designazione di terapia innovativa da parte della FDA statunitense	MT

Slide show Q1	23/04	CO
1st quarter results	23/04	CO
1st quarter results	23/04	CO
1st quarter results	23/04	CO
1st quarter report	23/04	CO
Shareholders meeting voting results	05/03	CO
Minutes of the general assembly	05/03	CO
Minutes of the general assembly	05/03	CO
Minutes of the general assembly	05/03	CO
Changes in management and corporate officers	16/02	CO
Slide show results	31/01	CO
Annual results	31/01	CO
Annual results	31/01	CO
Annual results	31/01	CO
SEC Filing 20 F	31/01	CO
Integrated report	31/01	CO
Financial report	31/01	CO
Annual Report	31/01	CO
Slide show Q3	24/10/23	CO
3rd quarter results	24/10/23	CO
3rd quarter results	24/10/23	CO
3rd quarter results	24/10/23	CO
3rd quarter report	24/10/23	CO
Slide show half-year results	18/07/23	CO
1st-half-year results	18/07/23	CO